By 2031 developing countries could need an estimated $35 billion to fight HIV/AIDS â€“ three times the amount currently spent, according to a Health Affairs study published Tuesday, the New York Times reports. The analysis â€“ based on economic models that assumed condoms, drugs and circumcision would be widespread – found that “even under the best case … more than one million people would be newly infected each year.
Access to Health Services
During a press conference on Thursday, Medecins Sans Frontieres (MSF) warned that the “global economic crisis and calls to commit funds to other health crises” threatened to undermine recent gains in the fight against HIV/AIDS, the Associated Press reports. MSF “says money for other health issues should be given in addition to money for [HIV/]AIDS” (11/5).
“As the London family planning summit looms closer, the debate begins over how much money is needed, what it should pay for and whether the fundamentally important issues of women’s reproductive rights will be addressed,” Sarah Boseley, health editor of the Guardian, writes in her “Global Health Blog.” Highlighting a new report from the Guttmacher Institute, which “assesses the scale of the unmet need for contraception,” she writes, “This report puts numbers and dollars into the frame ahead of the summit where the [Bill & Melinda Gates Foundation], [Department for International Development (DfID)], and others will be hoping big fat money pledges will be made, in the same way that the vaccines summit in London attracted massive donations — more money was raised than was hoped for.”
“A new UNAIDS/UNDP joint issues brief [.pdf] highlights the potential impacts of free trade agreements on public health,” UNAIDS reports in a feature story on its website. “The brief concludes that ‘to retain the benefits of [flexibilities in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)], countries at a minimum should avoid entering into free trade agreements that contain obligations that can impact on pharmaceutical price or availability,’” the article states. It adds that “the potential impact of a number of current or planned free trade agreement negotiations taking place across the world — particularly affecting countries in the Asia and the Pacific region — can hinder countries’ rights to implement such flexibilities” (6/1).
The Every Child Deserves a 5th Birthday theme for this week is mHealth, an e-mail alert from USAID reports. “While health effects typically take hold first in the richest parts of society then trickle down, mobile technology gives everyone access to the same information at the same time, so they can use…
“Around the world, frontline health workers are often the first link to lifesaving care and supplies, and in some cases they are the only link for families and communities in rural and impoverished areas,” Oying Rimon, a senior program officer in family health at the Bill & Melinda Gates Foundation,…
Growing Number Of Countries Adopting Flexible IP Regulations After India Issues Country's First Compulsory License
“A growing number of countries are adopting India’s intellectual property regulations, which give enough flexibility to local companies to produce generic versions of popular drugs to safeguard public health,” India’s Economic Times reports, noting, “In March, India issued the country’s first compulsory license, allowing [Natco Pharma] to legally manufacture and sell a low-cost version of German drugmaker Bayer AG’s patented cancer drug, Nexavar, at 3 percent of the original medicine’s price on the grounds that Bayer’s drug was not meeting public health requirement.” The news service writes, “Although multinational companies have criticized India for being lax in enforcing intellectual property (IP) laws, countries such as China, Argentina, and the Philippines are adopting similar provisions.”
“Progress in ensuring that women in poor countries have access to modern methods of contraception has stalled,” according to a new report (.pdf) by the United Nations Population Fund and the Guttmacher Institute, BMJ reports. The study “found that this year 645 million women of reproductive age (15 to 49 years) are using modern methods of contraception in the developing world, 42 million more than in 2008,” but “this rise is less than half the increase of 100 million between 2003 and 2008,” the journal writes.
AllAfrica.com/Guardian examine efforts to prevent and treat cervical cancer among women in Kenya, where an estimated 3,400 women die of the disease each year and only five percent receive screening. “Kenya’s national reproductive health strategic plan has addressed cervical cancer largely through the roll-out of a low-cost screening tool known as VIA (visual inspection of the cervix using ascetic acid),” but experts agree that more widespread use of cervical cancer vaccines and public education campaigns about the disease would be more effective at preventing and catching cases earlier, the news service reports. “Once the public owns this problem and pushes for it, … then the government would be forced to implement [a vaccine] strategy in full,” Lucy Muchiri, a pathologist specializing in cervical cancer at Kenyatta National Hospital and the University of Nairobi, said, the news service notes (Njoroge, 6/12).
The Miami Herald reports on Brazil’s national HIV/AIDS treatment and prevention program, writing, “By the mid-1990s, more effective and powerful antiretroviral therapies replaced the older treatments, and in 1996 Brazil declared that it would offer free antiretroviral treatment to all citizens with AIDS.” However, “the controversial program — the government broke international patent laws to mass-produce the drugs at a lower cost and recruited sex workers to help distribute condoms — may not survive for long, experts say,” the newspaper continues.